Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment
Ravi Bhatia(University of Alabama at Birmingham), Stephen J. Forman(City Of Hope National Medical Center), Charles L. Sawyers(Memorial Sloan Kettering Cancer Center), Daniel A. Arber(University of Chicago), Marilyn L. Slovak(City Of Hope National Medical Center), Rachel Gray(City Of Hope National Medical Center), Ning Niu(City Of Hope National Medical Center), David S. Snyder(City Of Hope National Medical Center), Melissa Holtz(City Of Hope National Medical Center)
Cited by 541
Related Papers
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
|Blood|2016|10.2k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k